Financial Statements - Asia Green Biotechnology Corp

For the Year ended Dec 31, 2021

Audited Financial Statements
Year End December 31, 2021

Management Discussion & Analysis
Year End December 31, 2021

For the Year ended Dec 31, 2020

Audited Financial Statements
Year End December 31, 2020

Management Discussion & Analysis
Year End December 31, 2020

For the Year ended Dec 31, 2019

Audited Financial Statements
Year End December 31, 2019

Management Discussion & Analysis
Year End December 31, 2019

LATEST NEWS

Asia Green Biotechnology Director: Bringing Canadian Cannabis Expertise to Asia (Investing News Network Interview) Asia Green Biotechnology Corp. And Inplanta Biotechnology Ltd. Announce Grant Of Full Registration Of “Bountiful” Hemp Cultivar Asia Green Biotechnology Corp. Enters Memorandum Of Agreement With Agricultural College In Cambodia To Evaluate Hemp Production Potential CTV: Medicinal cannabis mouthwash could help combat COVID-19 Asia Green Biotechnology Corp. Expands Technology License Agreement with Pathway Rx Inc. by Entering Corresponding Agreement with PNW Biosciences Inc. Forbes: ‘Cannabis Treats COVID-19’ Rallied Weed Stocks: Cannabis Could Aid Pandemic—If Someone Pays To Find Out Asia Green Biotechnology Corp. Enters Technology License Agreement with Pathway Rx Inc. for Asia Region and Agrees to Assist in Initiating Clinical Trials Covid-19 & Cannabis Research The GrowthOp: This Alberta scientist received worldwide attention for his cannabis and COVID-19 study. But getting funding and a clinical trial going in Canada remains a massive challenge NY Post: Scientists believe cannabis could help prevent and treat coronavirus